Structure |
Chemical Name |
CAS |
MF |
|
PF-562271 |
939791-38-5 |
C27H26F3N7O6S2 |
|
TAE226 (NVP-TAE226) |
761437-28-9 |
C23H25ClN6O3 |
|
R788(Fostamatinib disodium) |
1025687-58-4 |
C23H27FN6NaO9P |
|
PRT062607 (Hydrochloride) |
1370261-97-4 |
C19H24ClN9O |
|
R406 |
841290-81-1 |
C28H29FN6O8S |
|
WP1130 |
856243-80-6 |
C19H18BrN3O |
|
N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea |
1020172-07-9 |
C30H28FN7O3 |
|
PD173955 |
260415-63-2 |
C21H16Cl2N4OS |
|
GNF5 |
778277-15-9 |
C20H17F3N4O3 |
|
6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine |
934353-76-1 |
C21H25N7 |
|
[4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone |
1000669-72-6 |
C20H20N4O |
|
TCS 359 |
301305-73-7 |
C18H20N2O4S |
|
6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine |
873436-91-0 |
C18H21IN6O2S |
|
KW-2478 |
819812-04-9 |
C30H42N2O9 |
|
PF-04929113 |
908115-27-5 |
C25H30F3N5O4 |
|
4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide |
908112-43-6 |
C23H27F3N4O3 |
|
Onalespib |
912999-49-6 |
C24H31N3O3 |
|
N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]benzamidehydrochloride |
313553-47-8 |
C18H16N2OS |
|
PHA 767491 HYDROCHLORIDE |
845714-00-3 |
C12H11N3O |
|
ETHYL 8-METHOXY-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE-4-CARBOXYLATE |
869363-13-3 |
C25H15ClF2N4O2 |
|
CYC-116 |
693228-63-6 |
C18H20N6OS |
|
PF 477736 |
952021-60-2 |
C22H25N7O2 |
|
CCT129202 |
942947-93-5 |
C23H25ClN8OS |
|
PF-03814735 |
942487-16-3 |
C23H25F3N6O2 |
|
Abemaciclib mesylate (LY2835219) |
1231930-82-7 |
C28H36F2N8O3S |
|
PD0332991 Isethionate |
827022-33-3 |
C26H35N7O6S |
|
RG108 |
48208-26-0 |
C19H14N2O4 |
|
Hesperadin |
422513-13-1 |
C29H32N4O3S |
|
CK-636 |
442632-72-6 |
C16H16N2OS |
|
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- |
404951-53-7 |
C22H25N3O3 |
|
PFI-1 |
1403764-72-6 |
C16H17N3O4S |
|
CHIR-124 |
405168-58-3 |
C23H22ClN5O |
|
4SC-201 |
864814-88-0 |
C16H19N3O4S |
|
PF-3758309 |
898044-15-0 |
C25H30N8OS |
|
JNJ-26481585 |
875320-29-9 |
C21H26N6O2 |
|
GSK 525762A |
1260907-17-2 |
C22H22ClN5O2 |
|
PI3K/HDAC Inhibitor |
1339928-25-4 |
C23H24N8O4S |
|
RKI1447 |
1342278-01-6 |
C16H14N4O2S |
|
(Z,E)-5-(4-ETHYLBENZYLIDINE)-2-THIOXOTHIAZOLIDIN-4-ONE |
403811-55-2 |
C12H11NOS2 |
|
SPLITOMICIN |
5690-03-9 |
C13H10O2 |
|
9-Cyclopentyl-2-[[2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]-phenyl]amino]-7-methyl-7,9-dihydro-8H-purin-8-one |
1124329-14-1 |
C24H32N6O3 |
|
PCI 34051 |
950762-95-5 |
C17H16N2O3 |
|
SCRIPTAID |
287383-59-9 |
C18H18N2O4 |
|
TG003 |
300801-52-9 |
C13H15NO2S |
|
tasquinimod |
254964-60-8 |
C20H17F3N2O4 |
|
Aurora A Inhibitor I |
1158838-45-9 |
C31H31ClFN7O2 |
|
MK-5108 (VX-689) |
1010085-13-8 |
C22H21ClFN3O3S |
|
CCT 137690 |
1095382-05-0 |
C26H31BrN8O |
|
SCH900776 |
891494-63-6 |
C15H18BrN7 |
|
4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide |
844442-38-2 |
C16H17Cl2N5O2 |
|
AR-42 |
935881-37-1 |
C18H20N2O3 |
|
AMG 900 |
945595-80-2 |
C28H21N7OS |
|
PHA-848125 |
802539-81-7 |
C25H32N8O |
|
LY2603618 |
911222-45-2 |
C18H22BrN5O3 |
|
4-Chloro-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]benzamide |
188591-46-0 |
C15H12ClF3N2O3S |
|
1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
1396772-26-1 |
C32H37N5O3 |
|
UNC 1999 |
1431612-23-5 |
C33H43N7O2 |
|
UNC 0631 |
1320288-19-4 |
C37H61N7O2 |
|
BI-D1870 |
501437-28-1 |
C19H23F2N5O2 |
|
3-(Aminocarbonyl)-β-(3-cyclohexylpropyl)-N-hydroxy-1,2,4-oxadiazole-5-propanamide |
348622-88-8 |
C15H24N4O4 |
|
VU 0364439 |
1246086-78-1 |
C18H13Cl2N3O3S |
|
LY2090314 |
603288-22-8 |
C28H25FN6O3 |
|
AZD5363 |
1143532-39-1 |
C21H25ClN6O2 |
|
TTNPB (Arotinoid Acid) |
71441-28-6 |
C24H28O2 |
|
HMN-214 |
173529-46-9 |
C22H20N2O5S |
|
MK8245 |
1030612-90-8 |
C17H16BrFN6O4 |
|
Nepicastat hydrochloride |
170151-24-3 |
C14H16ClF2N3S |
|
NLG919 |
1402836-58-1 |
C18H22N2O |
|
indoleaMine-2,3-dioxygenase inhibitor INCB024360 |
914471-09-3 |
C9H7ClFN5O2 |
|
2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO- |
252935-94-7 |
C20H17Cl2N9O2 |
|
BMS-265246 |
582315-72-8 |
C18H17F2N3O2 |
|
Ribociclib |
1211441-98-3 |
C23H30N8O |
|
GW0742 |
317318-84-6 |
C21H17F4NO3S2 |
|
6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide |
801312-28-7 |
C27H26N4O5S |
|
AGI6780 |
1432660-47-3 |
C21H18F3N3O3S2 |
|
Octanoic acid, 6,8-bis[(phenylMethyl)thio]- |
95809-78-2 |
C22H28O2S2 |
|
A-674563 |
552325-73-2 |
C22H22N4O |
|
GSK 343 |
1346704-33-3 |
C31H39N7O2 |
|
PURVALANOL A |
212844-53-6 |
C19H25ClN6O |
|
S- (+)-Rolipram |
85416-73-5 |
C16H21NO3 |
|
(E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE |
658084-64-1 |
C24H29N3O2 |
|
GSK461364 |
929095-18-1 |
C27H28F3N5O2S |
|
SteMRegenin 1 |
1227633-49-9 |
C24H23N5OS |
|
PHT-427 |
1191951-57-1 |
C20H31N3O2S2 |
|
GSK 2334470 |
1227911-45-6 |
C25H34N8O |
|
EUK 134 |
81065-76-1 |
C18H18ClMnN2O4 |
|
1-AZAKENPAULLONE |
676596-65-9 |
C15H10BrN3O |
|
BML-275 |
1219168-18-9 |
C24H27Cl2N5O |
|
MLN0905 |
1228960-69-7 |
C24H25F3N6S |
|
AZD 1080 |
612487-72-6 |
C19H18N4O2 |
|
8-(2-Phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-onhydrochlorid |
5053-08-7 |
C15H21ClN2O2 |
|
SB 415286 |
264218-23-7 |
C16H10ClN3O5 |
|
ADL-5859 |
850173-95-4 |
C24H29ClN2O3 |
|
CCT128930 |
885499-61-6 |
C18H20ClN5 |
|
Tazemetostat (EPZ-6438) |
1403254-99-8 |
C34H44N4O4 |
|
PluriSln 1 |
91396-88-2 |
C12H11N3O |
|
Safinamide mesylate |
202825-46-5 |
C17H19FN2O2.CH4O3S |
|
5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine |
1224844-38-5 |
C15H15N7O |
|
EPZ004777 |
1338466-77-5 |
C28H41N7O4 |
|
Salirasib |
162520-00-5 |
C22H30O2S |